Every material Form 8-K Freshpet filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Freshpet reported third-quarter 2024 net sales of $253.4 million, up 26.3% from a year earlier, and net income of $11.9 million, compared with a net loss of $7.2 million in the prior-year quarter. The company raised its 2024 net sales and Adjusted EBITDA guidance, which signals higher expected full-year results for shareholders.
Q3 net sales of $253.4 million, up 26.3%, driven by volume gains of 26.1%
Q3 net income of $11.9 million, compared with a net loss of $7.2 million a year earlier
Q3 Adjusted EBITDA of $43.5 million, compared with $23.2 million a year earlier
2024 guidance: net sales of about $975 million (previously at least $965 million); Adjusted EBITDA of at least $155 million (previously at least $140 million); capital expenditures of about $180 million (previously about $200 million)
At its annual meeting on October 1, 2024, Freshpet stockholders approved a new 2024 Equity Incentive Plan that authorizes up to 1,450,000 shares and replaces the prior plan for new grants. All four director nominees were elected, KPMG LLP was ratified as auditor for 2024, and the say-on-pay proposal passed. The company also set its 2025 annual meeting for June 24, 2025, with shareholder nomination and proposal deadlines in early 2025.
The 2024 Equity Plan authorizes up to 1,450,000 shares, has no evergreen provision, and caps non-employee director pay at $750,000 in total value per calendar year, including cash fees.
Director David B. Biegger received 41,165,011 votes for and 137,349 against; Timothy R. McLevish received 41,119,866 for and 138,996 against.
Say-on-pay received 40,404,958 votes for and 890,056 against, with 2,856,494 broker non-votes.
The 2025 Annual Meeting is set for June 24, 2025; director nomination notices are due between February 24, 2025 and March 26, 2025.
Freshpet named Nicki Baty, a former president and general manager at Hill's Pet Nutrition U.S. with nearly 20 years at Colgate-Palmolive, as Chief Operating Officer effective September 1, 2024. Scott Morris, previously President and Chief Operating Officer, continues as President and Co-Founder, and Ms. Baty reports directly to CEO Billy Cyr.
Base salary of $525,000, with a target annual bonus of at least 60% of base salary
Inducement grant of restricted stock units covering 17,150 shares, plus a $500,000 cash bonus and $50,000 relocation support, subject to recoupment if she is not employed on September 1, 2026
Until May 10, 2025, her commercial responsibilities are limited to the Mass, Grocery, and Club channels
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Freshpet filing is on SEC EDGAR ↗. 8-K briefs of other companies →